Enabling competition between therapeutic alternatives is crucial to lowering costs for PBMs’ clients and patients.

A 2021 Evernorth study confirms that many women with insurance didn’t alter plans to grow their families despite COVID-19.

Employers can take the lead in addressing health disparities and implementing strategies to serve vulnerable populations.

By sharing her experience, Jillian hopes to encourage others to seek help and feel comfortable discussing their struggles.

Evernorth anticipates a dramatic shift in inflammatory and oncology treatments over the next five years, with dozens of biosimilars in the pipeline.